Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer.
Purpose: The aim of this study was to quantitatively compare the efficacy and safety of CDK4/6 inhibitors and PI3K/AKT/mTOR inhibitors for ER+/HER2− metastatic breast cancer. Methods: A parametric survival function was used to analyze the time course of overall survival (OS) and progression-free sur...
| Published in: | European Journal of Clinical Pharmacology Vol. 80; no. 9; pp. 1387 - 1398 |
|---|---|
| Main Authors: | , , , , |
| Format: | equations & formulas research systematic review tables/charts Journal Article |
| Published: |
Springer Nature
Sep2024
|
| Online Access: | View this record in EBSCOhost |